Advanced Marker Discovery SL (Amadix) is a developer and discoverer of cancer diagnostic products. The company provides test products and diagnostic tools for lung cancer, colon cancer and prostate cancer. It offers diagnostic tools that support the physician’s decisions about patient management. Amadix provides discovery, clinical validation, assay development, clinical utility, commercialization, in licensing and out licensing services. The company identifies, evaluates and in-licenses breakthrough discoveries in cancer diagnosis and develops them into marketable products. Its diagnostic tool offers prognostic, predictive and screening solutions, among others. The company sells products through a network of distributors in Spain. Amadix is headquartered in Valladolid, Spain.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.
The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.
Scope:
- The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
- The report analyzes all pipeline products in development for the company Advanced Marker Discovery SL
- The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
- The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
- The report provides detailed description of products in development, technical specification and functions
- The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.
Reasons to Buy:
- Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
- Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
- To formulate effective Research & Development strategies
- Develop market-entry and market expansion strategies
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
- Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
- Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio
Table of Contents
- Advanced Marker Discovery SL Company Overview
- Advanced Marker Discovery SL Company Snapshot
- Advanced Marker Discovery SL Pipeline Products and Ongoing Clinical Trials Overview
- Advanced Marker Discovery SL - Pipeline Analysis Overview
- Advanced Marker Discovery SL - Key Facts
- Advanced Marker Discovery SL - Major Products and Services
- Advanced Marker Discovery SL Pipeline Products by Development Stage
- Advanced Marker Discovery SL Ongoing Clinical Trials by Trial Status
- Advanced Marker Discovery SL Pipeline Products Overview
- 2nd Generation Prostate Cancer Test
- 2nd Generation Prostate Cancer Test Product Overview
- 3rd Generation Prostate Cancer Test
- 3rd Generation Prostate Cancer Test Product Overview
- 4th Generation Prostate Cancer Test
- 4th Generation Prostate Cancer Test Product Overview
- Biomarker Diagnostic Test - Ovarian Cancer
- Biomarker Diagnostic Test - Ovarian Cancer Product Overview
- DiagnoLung
- DiagnoLung Product Overview
- PancreaDix
- PancreaDix Product Overview
- Predictive Diagnostic Test - Lung Cancer
- Predictive Diagnostic Test - Lung Cancer Product Overview
- PreveCol
- PreveCol Product Overview
- PreveCol Clinical Trial
- Prognostic And Predictive Test - Colon cancer
- Prognostic And Predictive Test - Colon cancer Product Overview
- Prognostic Test - Lung Cancer
- Prognostic Test - Lung Cancer Product Overview
- Prognostic Test - Prostate Cancer
- Prognostic Test - Prostate Cancer Product Overview
- Prostate Cancer - Genetic Test
- Prostate Cancer - Genetic Test Product Overview
- Urine Based Diagnostic Test - Prostate Cancer
- Urine Based Diagnostic Test - Prostate Cancer Product Overview
- Advanced Marker Discovery SL - Key Competitors
- Advanced Marker Discovery SL - Key Employees
- Advanced Marker Discovery SL - Locations And Subsidiaries
- Head Office
- Other Locations & Subsidiaries
- Recent Developments
- Advanced Marker Discovery SL, Recent Developments
- Jan 23, 2024: FDA Grants Breakthrough Device Designation to Amadix´s Preventive Screening Blood Test for Colorectal Cancer
- Appendix
- Methodology
- About the Analyst
- Contact the Publisher
- Disclaimer
- Advanced Marker Discovery SL Pipeline Products and Ongoing Clinical Trials Overview
- Advanced Marker Discovery SL Pipeline Products by Equipment Type
- Advanced Marker Discovery SL Pipeline Products by Indication
- Advanced Marker Discovery SL Ongoing Clinical Trials by Trial Status
- Advanced Marker Discovery SL, Key Facts
- Advanced Marker Discovery SL, Major Products and Services
- Advanced Marker Discovery SL Number of Pipeline Products by Development Stage
- Advanced Marker Discovery SL Pipeline Products Summary by Development Stage
- Advanced Marker Discovery SL Ongoing Clinical Trials by Trial Status
- Advanced Marker Discovery SL Ongoing Clinical Trials Summary
- 2nd Generation Prostate Cancer Test - Product Status
- 2nd Generation Prostate Cancer Test - Product Description
- 3rd Generation Prostate Cancer Test - Product Status
- 3rd Generation Prostate Cancer Test - Product Description
- 4th Generation Prostate Cancer Test - Product Status
- 4th Generation Prostate Cancer Test - Product Description
- Biomarker Diagnostic Test - Ovarian Cancer - Product Status
- Biomarker Diagnostic Test - Ovarian Cancer - Product Description
- DiagnoLung - Product Status
- DiagnoLung - Product Description
- PancreaDix - Product Status
- PancreaDix - Product Description
- Predictive Diagnostic Test - Lung Cancer - Product Status
- Predictive Diagnostic Test - Lung Cancer - Product Description
- PreveCol - Product Status
- PreveCol - Product Description
- PreveCol - Development and Validation of a Blood Test for Early Diagnosis of Colorectal Cancer Based on Molecular Markers and Risk Factors Identified with Artificial Intelligence Tools
- PreveCol - Evaluation of PreveCol's Efficiency As a Second Line Method for the Early Colorectal Cancer Detection
- PreveCol - Observational Cross-reactivity Study to Evaluate the Specificity of a Blood Test for Colorectal Cancer Diagnosis Based on Molecular Markers and Risk Factors Identified With Artificial Intelligence Tools
- Prognostic And Predictive Test - Colon cancer - Product Status
- Prognostic And Predictive Test - Colon cancer - Product Description
- Prognostic Test - Lung Cancer - Product Status
- Prognostic Test - Lung Cancer - Product Description
- Prognostic Test - Prostate Cancer - Product Status
- Prognostic Test - Prostate Cancer - Product Description
- Prostate Cancer - Genetic Test - Product Status
- Prostate Cancer - Genetic Test - Product Description
- Urine Based Diagnostic Test - Prostate Cancer - Product Status
- Urine Based Diagnostic Test - Prostate Cancer - Product Description
- Advanced Marker Discovery SL, Key Employees
- Advanced Marker Discovery SL, Other Locations
- Advanced Marker Discovery SL, Subsidiaries
- Glossary
- Advanced Marker Discovery SL Pipeline Products by Equipment Type
- Advanced Marker Discovery SL Pipeline Products by Development Stage
- Advanced Marker Discovery SL Ongoing Clinical Trials by Trial Status
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- ONCOVISION
- Healx Ltd
- Oryzon Genomics SA
- Applied Research using OMIC Sciences SL
- Medicago AB
